Janssen Research & Development, LLC

JACI-35.054

clinicaltrials.gov

ACI-35.030

clinicaltrials.gov

NCT02851212

Phase 1Completed201644 people1 Aug 2016clinicaltrials.gov

NCT02851095

Phase 1Completed201644 people1 Aug 2016clinicaltrials.gov

NCT02846532

Phase 3Completed2016112 people27 Jul 2016clinicaltrials.gov

NCT02846506

Phase 1Completed201644 people27 Jul 2016clinicaltrials.gov

NCT02811978

Phase 3Completed201681 people23 Jun 2016clinicaltrials.gov

NCT02703272

Phase 3Terminated201672 people9 Mar 2016clinicaltrials.gov

NCT02634463

Phase 1Completed201581 people18 Dec 2015clinicaltrials.gov

NCT02617810

Phase 1Completed201518 people1 Dec 2015clinicaltrials.gov

NCT02611518

Phase 1Completed201632 people20 Nov 2015clinicaltrials.gov

NCT02568176

Phase 1Completed201571 people5 Oct 2015clinicaltrials.gov

NCT02556203

CollaboratorPhase 3Terminated20151,653 people22 Sept 2015clinicaltrials.gov

NCT02541383

CollaboratorPhase 3Completed20151,085 people4 Sept 2015clinicaltrials.gov

NCT02462473

Phase 2Terminated20159 people4 Jun 2015clinicaltrials.gov

NCT02397382

Phase 1Completed201516 people25 Mar 2015clinicaltrials.gov

NCT02365597

Phase 2Active, not recruiting2015239 people19 Feb 2015clinicaltrials.gov

NCT02313909

CollaboratorPhase 3Terminated20147,213 people10 Dec 2014clinicaltrials.gov

NCT02301234

Phase 3Completed2015111 people25 Nov 2014clinicaltrials.gov

NCT02293395

Phase 2Completed20153,037 people18 Nov 2014clinicaltrials.gov

NCT02252172

Phase 3Completed2015737 people30 Sept 2014clinicaltrials.gov

NCT02243202

Phase 2Completed2014335 people17 Sept 2014clinicaltrials.gov